ClinicalTrials.Veeva

Menu

The United Kingdom Multiple Sclerosis Register Covid-19 Substudy (UKMSRCV19)

S

Swansea University

Status

Unknown

Conditions

COVID-19
Multiple Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT04354519
16SW0194

Details and patient eligibility

About

The aim of the study is to understand the impact of COVID-19 on People with Multiple Sclerosis in the United Kingdom.

Full description

Study objectives

  1. To identify the incidence of upper respiratory tract symptoms: fever, cough and breathing difficulties, other symptoms suggestive of COVID-19 infection, respiratory tract infections suggestive of COVID-19, and COVID-19 confirmed by laboratory testing among the UK MS population
  2. To establish if some DMDs increase the risk of COVID-19 infection
  3. To determine the incidence and effectiveness of self-isolation in the MS population. To examine the impact self-isolation has on mood, fatigue, and other routinely collected patient reported outcome measures from the MS Register.
  4. To determine the clinical outcome of respiratory tract infections, including confirmed and suspected cases of COVID-19, in terms of symptoms, time to recovery, hospital admission, requirement for ventilation, and death.
  5. To determine the longer-term impact of COVID-19 on MS, using routinely collected MS outcomes in the MS register, including impact on disability, relapses and changes in DMDs as assessed at 3 monthly intervals.
  6. To determine where people are obtaining their health information during the COVID-19 outbreak.
  7. To establish changes in DMDs prior to and as a result of symptoms related and unrelated to COVID-19

Enrollment

3,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >18 and confirmed diagnosis of MS, enrolled on UK MS Register

Exclusion criteria

  • None of the above

Trial design

3,000 participants in 3 patient groups

Confirmed Cases
Description:
Diagnosed by health professional / Covid-19 test Monitored through fortnightly questionnaires
Not Covid-19 cases
Description:
Through self report no suspicion of COVID-19, tested by fortnightly questionnaire. non Covid Cases can become COVID cases through self report.
Suspected Covid-19 Cases
Description:
Participants that are suspected of having Covid-19 but this has not been confirmed by health professional or Covid-19 test has not been performed. Fortnighly questionnaire

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Katie A Tuite-Dalton, BSc; Rod M Middleton, MBA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems